Blood Pressure Measure Device MarketSize, Share & Industry Analysis, 2026-2034By TypeBy ApplicationBy TechnologyBy Distribution ChannelBy Connectivity

A blood pressure measurement device is an instrument used to record arterial blood pressure, ranging from manual aneroid and mercury sphygmomanometers to fully automated digital and ambulatory monitors worn for extended periods. These devices are built around wrist or upper-arm cuff form factors and are purchased by hospitals, clinics, physical examination centers, and increasingly by individual patients managing hypertension at home. Buyers range from institutional procurement teams sourcing clinical-grade equipment to retail and online consumers purchasing a monitor for personal use.

The global blood pressure measure device market is valued at USD 4.1 billion in 2025 and is set to reach USD 8.97 billion by 2034, a compound annual growth rate of 9.04% across the 2026-2034 forecast period. The study tracks the market across USD 2.4 billion in 2020, USD 3.75 billion in 2024, USD 4.49 billion in 2026 and USD 6.44 billion in 2030.

On the type axis, growth rates run from 7.54% for Arm Measurement up to 11.72% for Wrist Measurement. Arm Measurement carries the volume: USD 2.79 billion and 68% of revenue in 2025, USD 5.38 billion and 60% in 2034. The lines gaining share are Wrist Measurement. Arm Measurement lose share without losing revenue.

By application, Hospitals accounts for 32% of 2025 revenue at USD 1.31 billion, reaching USD 2.33 billion and 26% by 2034. Home Care grows faster at 12.53% against 6.61%, moving from 28% of revenue to 37% by 2034. This axis divides the same revenue as the type split rather than adding to it, so the two are read together rather than summed.

North America is the largest region at 34% of 2025 revenue, worth USD 1.39 billion and reaching USD 2.69 billion by 2034. Asia Pacific follows at 28%, moving from USD 1.14 billion to USD 3.05 billion, and Middle East and Africa is the smallest at 6%. Share shifts toward Asia Pacific over the forecast period, which is what makes the regional split worth reading rather than assuming.

The 2025 total is triangulated from published sources and category proxies rather than an independently sourced count. Segment, regional and country splits are estimated on the same basis, which bounds the precision of the figures above. Coverage runs to five regions, two type lines and five segmentation axes across a fifteen-year window.

• Revenue grows from USD 4.1 billion in 2025 to USD 8.97 billion in 2034, a compound annual rate of 9.04%, having reached USD 3.75 billion in 2024 from USD 2.4 billion in 2020.
• Arm Measurement is the largest type line at USD 2.79 billion in 2025, a 68% share, reaching USD 5.38 billion and 60% of revenue by 2034.
• Wrist Measurement is the fastest-growing line at 11.72%, lifting its share from 32% in 2025 to 40% in 2034 and its revenue from USD 1.31 billion to USD 3.59 billion.
• Against a base case of USD 8.97 billion in 2034, the study also reports a bear case at USD 7.61 billion and a bull case at USD 9.98 billion, with the assumptions behind each set out separately.
• North America holds 34% of global revenue in 2025 at USD 1.39 billion, the largest of the five regions tracked, and reaches USD 2.69 billion by 2034.
• The United States accounts for 84.89% of North America in the base year, worth USD 1.18 billion in 2025 and reaching USD 2.29 billion by 2034, the worked country example carried through that region's chapters.
• The study covers 2020 through 2034 with 2025 as the base year, reporting five regions and five segmentation axes separately, with revenue, share and a growth rate for every line in each year.

Three movements define the forecast period in the global blood pressure measure device market: how the type mix changes, where regional weight shifts, and the rate at which the total compounds.

Not one of them points downward. Growth is everywhere in absolute terms, and the interest is entirely in where it lands.

Wrist Measurement grows faster than Arm Measurement. Wrist Measurement grows at 11.72% across 2026-2034 against 7.54% for Arm Measurement, the widest spread on the type axis. By 2034 the two sit at 40% and 60% of revenue, against 32% and 68% in 2025. In absolute terms Wrist Measurement rises from USD 1.31 billion to USD 3.59 billion, while Arm Measurement rises from USD 2.79 billion to USD 5.38 billion. Both grow; the gap is wide enough to reshape the mix inside a single forecast window.

The regional balance moves. Asia Pacific moves from 28% of revenue in 2025 to 34% in 2034, worth USD 1.14 billion rising to USD 3.05 billion. The offsetting side is North America at 34% moving to 30%, Europe at 25% moving to 23%, Latin America at 7% moving to 7%, Middle East and Africa at 6% moving to 6%, none of which contracts. Growth is therefore not something a participant inherits from the market; it depends on which regions its revenue is weighted toward.

Fifteen years without a discontinuity. Reading the series: USD 2.4 billion in 2020, USD 3.75 billion in 2024, USD 4.1 billion in 2025, USD 4.49 billion in 2026, USD 6.44 billion in 2030 and USD 8.97 billion in 2034. The forecast rate of 9.04% sits against 11.3% over the historical period, so the projection extends an observed trend instead of proposing a new one. That moves the planning question away from timing a turn and onto the type and regional mixes, where the actual movement is.

Growth is concentrated in Wrist Measurement

Growth in the global blood pressure measure device market comes from three measurable sources over 2026-2034: the market's own compounding at 9.04%, the share gained by faster-growing type lines, and expansion in the regions taking a larger part of global revenue.

The bear case and what drives it

Where the forecast could be beaten

The total depends on a single line

USD 1.39 billion of 2025 revenue is generated in North America, 34% of the global blood pressure measure device market rising to USD 2.69 billion in 2034. By revenue it sits first across the study, and the ranking does not change between 2025 and 2034.

By 2034 the share stands at 30%, a shift in share rather than in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.

Arm Measurement leads here as it does globally, at 68% of 2025 revenue, and Wrist Measurement again grows fastest at 11.72%. North America is reported axis by axis and country by country in the full study.

84.89% of North America's base-year revenue comes from the United States; USD 1.18 billion, rising to USD 2.29 billion by 2034. 84.89% of the region in 2025 means the regional figures are, in practice, a view of this market with others attached. Set against USD 1.39 billion and USD 2.69 billion for the region, it is why this market rather than a smaller one is the one reported in full.

The type pattern in the United States is the global one: 68% of 2025 revenue in Arm Measurement, 60% by 2034, against 11.72% growth in Wrist Measurement taking it from 32% to 40%. Since 84.89% of North America's revenue is generated here, the regional numbers inherit this market's mix rather than smoothing it out. Per-type revenue for the United States appears on its own in the full report.

Blood pressure measurement devices sold in the United States are regulated by the Food and Drug Administration as medical devices, most commonly cleared through the premarket notification pathway upon a showing of substantial equivalence to an already-legally-marketed predicate device. Manufacturers must register their establishment, list the device, and operate under the FDA's Quality System Regulation covering design controls and production. Labeling must disclose intended use, accuracy claims, and clinical performance data validated against a recognized accuracy protocol. Devices intended for home use face additional scrutiny regarding user comprehension and instructions for lay operators, while accessories and connected software components may trigger separate review.

The suppliers tracked in this study (Geratherm, TaiDoc Technology, Lanaform, Bosch + Sohn, Visiomed, Riester, Hannox, CA-MI, ERKA, BIOSAM Biomedical Instrument, Isansys Lifecare, Abbott, Promed Group, Omron, Troge Medical, Suzuken Company, Withings, Beurer and Eocene Systems) compete in the United States across the type lines above. Two different problems sit on the same axis: holding Arm Measurement at 68% of 2025 revenue, and taking Wrist Measurement while it grows at 11.72%. Per-company positioning and share at country level are in the full report only.

Within North America, Canada accounts for 15.11% of regional revenue and 5.12% of the global total, worth USD 0.21 billion in 2025 and USD 0.4 billion by 2034.

USD 1.03 billion of 2025 revenue is generated in Europe, 25% of the global blood pressure measure device market rising to USD 2.06 billion in 2034. Among the five regions it ranks third by revenue in both years.

Its share moves to 23% by 2034, a shift in share rather than in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.

Arm Measurement leads here as it does globally, at 68% of 2025 revenue, and Wrist Measurement again grows fastest at 11.72%. Europe is reported axis by axis and country by country in the full study.

28.16% of Europe's base-year revenue comes from Germany; USD 0.29 billion, rising to USD 0.58 billion by 2034. It accounts for 28.16% of regional revenue in the base year, the largest single share without dominating the region outright. Against regional totals of USD 1.03 billion in 2025 and USD 2.06 billion in 2034, it is the country the full report breaks out in detail.

Composition here matches the global split: the largest line is Arm Measurement at 68% of 2025 revenue, easing to 60% by 2034, and the fastest is Wrist Measurement at 11.72%, from 32% to 40%. Because the country carries 28.16% of Europe, a movement in its own mix shows up in the regional totals rather than being averaged away by neighbouring markets. Germany carries its own type breakdown in the full report.

As an EU member state, Germany applies the EU Medical Device Regulation to blood pressure measurement devices, with conformity assessed against the applicable risk class before a CE mark can be affixed. Non-invasive monitors typically fall under a moderate risk class requiring Notified Body involvement, technical documentation, and a declaration of conformity demonstrating compliance with harmonized standards covering electrical safety, electromagnetic compatibility, and clinical accuracy validation. The national competent authority, BfArM, oversees market surveillance, vigilance reporting, and enforcement within Germany, while manufacturers must also satisfy post-market clinical follow-up obligations and maintain a quality management system aligned with the relevant harmonized standard for medical device manufacturing.

Competition in Germany runs between the suppliers this study tracks: Geratherm, TaiDoc Technology, Lanaform, Bosch + Sohn, Visiomed, Riester, Hannox, CA-MI, ERKA, BIOSAM Biomedical Instrument, Isansys Lifecare, Abbott, Promed Group, Omron, Troge Medical, Suzuken Company, Withings, Beurer and Eocene Systems. Arm Measurement, at 68% of 2025 revenue, is where the volume sits, and Wrist Measurement, growing at 11.72%, is where position changes hands over the forecast period.

5.61% of global revenue is generated in the United Kingdom; USD 0.23 billion in 2025, reaching USD 0.45 billion in 2034, and 22.33% of Europe.

Within Europe, France accounts for 18.45% of regional revenue and 4.63% of the global total, worth USD 0.19 billion in 2025 and USD 0.37 billion by 2034.

Asia Pacific holds 28% of the global blood pressure measure device market in 2025, worth USD 1.14 billion with USD 3.05 billion projected for 2034. It is a leading region on this axis, second by revenue throughout the period.

By 2034 the share has moved up to 34%, so the region grows faster than the market's 9.04% and takes a larger part of the revenue added by 2034 than its 2025 weight implies.

Within the region the type split tracks the global one; 68% of 2025 revenue in Arm Measurement, fastest growth of 11.72% in Wrist Measurement. Asia Pacific is reported axis by axis and country by country in the full study.

35.09% of Asia Pacific's base-year revenue comes from China; USD 0.4 billion, rising to USD 1.07 billion by 2034. 35.09% of the region in the base year makes it the largest market here without making it the region. Regional revenue of USD 1.14 billion in 2025 and USD 3.05 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

The type pattern in China is the global one: 68% of 2025 revenue in Arm Measurement, 60% by 2034, against 11.72% growth in Wrist Measurement taking it from 32% to 40%. Because the country carries 35.09% of Asia Pacific, a movement in its own mix shows up in the regional totals rather than being averaged away by neighbouring markets. China carries its own type breakdown in the full report.

Blood pressure measurement devices marketed in China fall under the oversight of the National Medical Products Administration, which classifies non-invasive monitors as a regulated medical device requiring a registration certificate before sale. Manufacturers, whether domestic or foreign, must complete product testing against applicable Chinese national standards, submit clinical evaluation data, and, for imported devices, appoint a local agent responsible for regulatory liaison and post-market reporting. Facilities must operate under China's medical device Good Manufacturing Practice requirements, and labeling together with instructions for use must appear in Chinese and disclose intended use, accuracy performance, and storage conditions. Provincial-level authorities support enforcement and market surveillance activity.

Geratherm, TaiDoc Technology, Lanaform, Bosch + Sohn, Visiomed, Riester, Hannox, CA-MI, ERKA, BIOSAM Biomedical Instrument, Isansys Lifecare, Abbott, Promed Group, Omron, Troge Medical, Suzuken Company, Withings, Beurer and Eocene Systems are the suppliers covered in China. Arm Measurement, at 68% of 2025 revenue, is where the volume sits, and Wrist Measurement, growing at 11.72%, is where position changes hands over the forecast period.

Within Asia Pacific, Japan accounts for 21.93% of regional revenue and 6.1% of the global total, worth USD 0.25 billion in 2025 and USD 0.67 billion by 2034.

Within Asia Pacific, India accounts for 14.91% of regional revenue and 4.15% of the global total, worth USD 0.17 billion in 2025 and USD 0.46 billion by 2034.

Latin America holds 7% of the global blood pressure measure device market in 2025, worth USD 0.29 billion on the way to USD 0.63 billion by 2034. Among the five regions it ranks fourth by revenue in both years.

7% of global revenue sits here in 2034, below the 2025 level, a shift in share rather than in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.

Arm Measurement leads here as it does globally, at 68% of 2025 revenue, and Wrist Measurement again grows fastest at 11.72%. Latin America is reported axis by axis and country by country in the full study.

USD 0.16 billion of Latin America's 2025 revenue is generated in Brazil, the region's largest market, reaching USD 0.35 billion by 2034. It accounts for 55.17% of regional revenue in the base year, the largest single share without dominating the region outright. Set against USD 0.29 billion and USD 0.63 billion for the region, it is why this market rather than a smaller one is the one reported in full.

Composition here matches the global split: the largest line is Arm Measurement at 68% of 2025 revenue, easing to 60% by 2034, and the fastest is Wrist Measurement at 11.72%, from 32% to 40%. Since 55.17% of Latin America's revenue is generated here, the regional numbers inherit this market's mix rather than smoothing it out. Brazil carries its own type breakdown in the full report.

In Brazil, blood pressure measurement devices are regulated by ANVISA, the national health surveillance agency, which requires products to obtain a registration or notification depending on assigned risk classification before they can be legally marketed. Manufacturers must demonstrate conformity with applicable Brazilian technical standards covering safety and performance, maintain Good Manufacturing Practice certification for the production site, and submit technical documentation supporting the device's intended use and accuracy claims. Local representation is required for foreign manufacturers, and product labeling together with instructions for use must be provided in Portuguese. ANVISA also oversees post-market vigilance, adverse event reporting, and periodic renewal of the registration.

Geratherm, TaiDoc Technology, Lanaform, Bosch + Sohn, Visiomed, Riester, Hannox, CA-MI, ERKA, BIOSAM Biomedical Instrument, Isansys Lifecare, Abbott, Promed Group, Omron, Troge Medical, Suzuken Company, Withings, Beurer and Eocene Systems are the suppliers covered in Brazil. Two different problems sit on the same axis: holding Arm Measurement at 68% of 2025 revenue, and taking Wrist Measurement while it grows at 11.72%.

Mexico is sized at USD 0.09 billion in 2025, rising to USD 0.19 billion by 2034; 2.2% of global revenue and 31.03% of Latin America. It is reported separately from Brazil across every segmentation axis in the full report.

In Middle East and Africa, 6% of global revenue puts 2025 at USD 0.25 billion with USD 0.54 billion projected for 2034. By revenue it sits fifth across the study, and the ranking does not change between 2025 and 2034.

Share settles at 6% in 2034, while nothing contracts here; other regions simply grow faster, which shows up as relative weight rather than as falling revenue.

Within the region the type split tracks the global one; 68% of 2025 revenue in Arm Measurement, fastest growth of 11.72% in Wrist Measurement. Middle East and Africa is reported axis by axis and country by country in the full study.

USD 0.1 billion of Middle East and Africa's 2025 revenue is generated in Saudi Arabia, the region's largest market, reaching USD 0.22 billion by 2034. 40% of the region in the base year makes it the largest market here without making it the region. Regional revenue of USD 0.25 billion in 2025 and USD 0.54 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

The type pattern in Saudi Arabia is the global one: 68% of 2025 revenue in Arm Measurement, 60% by 2034, against 11.72% growth in Wrist Measurement taking it from 32% to 40%. Its 40% weight in Middle East and Africa means those movements carry straight into the regional totals. Per-type revenue for Saudi Arabia appears on its own in the full report.

Blood pressure measurement devices sold in Saudi Arabia are regulated by the Saudi Food and Drug Authority, which requires the device and its manufacturer to be listed on the national medical device registration system before market entry. Classification follows a risk-based approach broadly aligned with the Gulf Cooperation Council's harmonized medical device framework, and conformity is typically demonstrated through recognition of an existing approval from a reference regulatory authority alongside local technical file review. Manufacturers must appoint an authorized local representative, ensure labeling and instructions are available in Arabic, and comply with post-market surveillance and adverse event reporting obligations set by the authority.

Competition in Saudi Arabia runs between the suppliers this study tracks: Geratherm, TaiDoc Technology, Lanaform, Bosch + Sohn, Visiomed, Riester, Hannox, CA-MI, ERKA, BIOSAM Biomedical Instrument, Isansys Lifecare, Abbott, Promed Group, Omron, Troge Medical, Suzuken Company, Withings, Beurer and Eocene Systems. Two different problems sit on the same axis: holding Arm Measurement at 68% of 2025 revenue, and taking Wrist Measurement while it grows at 11.72%.

Within Middle East and Africa, South Africa accounts for 24% of regional revenue and 1.46% of the global total, worth USD 0.06 billion in 2025 and USD 0.14 billion by 2034.

Request this sample to see the full data tables and segment-level detail behind this analysis.

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by Type, Application, Technology, Distribution Channel, Connectivity, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.